These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17385437)

  • 1. [Correlation of uric acid, APO-CIII, and apo-E in healthy individuals and patients with coronary heart disease and hypertensive disease].
    Boĭko EP; Kaneva AM; Ovechkin AO; Potolitsyna NN
    Klin Lab Diagn; 2007 Jan; (1):16-8. PubMed ID: 17385437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia].
    Boĭko ER; Ovechkin AO; Kaneva AM; Potolitsyna NN; Boĭko SG
    Ter Arkh; 2007; 79(12):51-4. PubMed ID: 18220032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects.
    Liberopoulos EN; Miltiadous GA; Athyros VG; Ganotakis M; Cariolou M; Bairaktari E; Elisaf MS
    J Investig Med; 2005 Apr; 53(3):116-22. PubMed ID: 15921030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
    Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII.
    Rifai N; Silverman LM
    Clin Chem; 1986 Oct; 32(10):1969-72. PubMed ID: 3093121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
    Hiukka A; Fruchart-Najib J; Leinonen E; Hilden H; Fruchart JC; Taskinen MR
    Diabetologia; 2005 Jun; 48(6):1207-15. PubMed ID: 15864534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.
    Hirano T; Sakaue T; Misaki A; Murayama S; Takahashi T; Okada K; Takeuchi H; Yoshino G; Adachi M
    Kidney Int; 2003 Jun; 63(6):2171-7. PubMed ID: 12753304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E; Herbeth B; Paille F; Steinmetz J; Artur Y; Siest G
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins in patients with isolated hyperuricemia.
    Tinahones FJ; Vazquez F; Soriguer FJ; Collantes E
    Adv Exp Med Biol; 1998; 431():61-7. PubMed ID: 9598032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences.
    Noma A; Hata Y; Goto Y
    Clin Chim Acta; 1991 Jun; 199(2):147-57. PubMed ID: 1908362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
    Lee SJ; Sacks FM
    Am J Cardiol; 2003 Jul; 92(2):121-4. PubMed ID: 12860210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo.
    Bach-Ngohou K; Nazih H; Nazih-Sanderson F; Zaïr Y; Le Carrer D; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2001 Dec; 25(12):1752-8. PubMed ID: 11781754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
    Paulweber B; Friedl W; Krempler F; Humphries SE; Sandhofer F
    Atherosclerosis; 1988 Oct; 73(2-3):125-33. PubMed ID: 2903749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary heart disease, echo-Doppler evidence of peripheral arterial disease and polymorphism of apolipoprotein B gene and Apo AI/CIII cluster.
    De Lorenzo F; Rubba P; Monticelli A; Cocozza S
    Angiology; 1993 Oct; 44(10):785-90. PubMed ID: 8105730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII.
    Shoulders CC; Harry PJ; Lagrost L; White SE; Shah NF; North JD; Gilligan M; Gambert P; Ball MJ
    Atherosclerosis; 1991 Apr; 87(2-3):239-47. PubMed ID: 1906714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apolipoproteins AI, B100, CII, CIII and E in human cerebrospinal fluid].
    Liu Y; Liu B; Yin J; Wu K; Wu L
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):352-4. PubMed ID: 1814810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.